The Safety and PK Study of Inhaled ICF004 in Healthy Chinese Volunteers

NCT07719218 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Interstitial Lung Disease (ILD)
Healthy Volunteers

Interventions

DRUG: ICF004
DRUG: Placebo
DRUG: ICF004
DRUG: Pacebo

Sponsor

Ruijin Hospital